openPR Logo
Press release

Global Ovarian Cancer Diagnostics Market Share, Trends Analysis, Growth Facts and Industry Forecast to 2022

04-26-2018 02:36 PM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

A freshly compiled business intelligent report, titled “Ovarian Cancer Diagnostics Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been publicized to the vast archive of Fact.MR online repository. This 170 page study delivers all the vital details and information required to know about ovarian cancer diagnostics market current as well as future prospects. The analysts of the study have gone through extensive research methodologies in order to generate data and information that reflects the latest market undercurrents and industry trends. For a deeper understanding of the market, a sub-category level analysis has been elaborated, by which readers and investors of the report will able to know that where the market stands to gain.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=51

The American Cancer Society estimates that approx. 20,000 women will be diagnosed with ovarian cancer in the U.S. and more than 14,000 will lose their lives because of it in 2017 alone. In terms of deaths, this form of cancer ranks fifth and it led to more deaths than any other female reproductive system form of cancer. The chance of a women developing ovarian cancer during her life is 1 in 75 and the chance of her dying is 1 in 100. It is mainly seen in older women above the age of 63 years. Even though the rate at which women have been diagnosed with ovarian cancer has been falling, it is still a public health menace that needs to be tackled effectively. This is where the ovarian cancer diagnostics market can play a crucial role. The global ovarian cancer diagnostics market is predicted to grow with a CAGR of 8.7% and be worth nearly US$ 1 billion in 2022, from less than US$ 640 million in 2017.

Epithelial Tumours Segment larger than the other two combined

The Epithelial Tumours Segment is anticipated to grow to almost US $ 880 million by the end of the forecast period and it already accounts for an 11% revenue share in 2017 itself. North America alone represents almost 2/5th of the market and it should touch US$ 330 million by the end of 2022. The germ cell carcinoma tumours segment is much smaller by comparison and is only poised to be a US$ 50 million market by the end of the five year study. Even the stromal carcinoma tumours segment is marginal at best when contrasted with epithelial tumours in the ovarian cancer diagnostics market. The stromal carcinoma tumours segment is likely to be valued at only US$ 28 million in 2017.

Hospital associated and independent diagnostic labs most vital

The hospital associated lab segment is expected to record a CAGR of 7.8% from 2017-2022 and rise from just under $300 million in 2017 to roughly US$ 440 million in 2022. Independent diagnostic labs are the second most important segment in the ovarian cancer diagnostics market and are estimated to be worth US$ 161 million in 2017. While North America might account for the largest contribution, Europe should record a higher CAGR of 9.5% making it more attractive to target in the long term.

Focus on CA 125 test segment in the ovarian cancer diagnostics market

The CA 125 test segment could be worth roughly US$ 440 million in 2022 and some key stakeholders may decide to focus on this lucrative test over all other available alternatives in the ovarian cancer diagnostics market. However, the HER 2 segment also accounts for a 3.1% revenue share in 2017 and it would be unwise to do so. On the other hand, the BRCA segment in North America alone could grow with a CAGR of 8.3% for the period 2017-2022, making it imperative for companies to hedge their bets in the ovarian cancer diagnostics market.

Browse Full Report with TOC@ https://www.factmr.com/report/51/ovarian-cancer-diagnostics-market

Table of Contents:

Chapter 1. Global Ovarian Cancer Diagnostics Market – Executive Summary. 26

Chapter 2. Global Ovarian Cancer Diagnostics Market Overview. 28
2.1. Introduction. 28
2.1.1. Global Ovarian Cancer Diagnostics Market Taxonomy. 28
2.1.2. Global Ovarian Cancer Diagnostics Market Definition. 28
2.2. Global Ovarian Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022. 28
2.2.1. Global Ovarian Cancer Diagnostics Market Y-o-Y Growth. 28
2.3. Global Ovarian Cancer Diagnostics Market Dynamics. 29
2.3.1. Drivers. 29
2.3.2. Restraints. 29
2.3.3. Trends. 29
2.4. Supply Chain. 30
2.5. Epidemiology. 30
2.6. List of Distributors. 30
2.7. Average Pricing Analysis. 30
2.8. Regulations. 30
2.9. Key Participants Market Presence (Intensity Map) By Region. 31

Chapter 3. Global Ovarian Cancer Diagnostics Market Analysis and Forecast By Cancer Type. 32
3.1. Global Ovarian Cancer Diagnostics Market Size and Forecast By Cancer Type, 2012-2022. 32
3.1.1. Epithelial Tumors Ovarian Cancer Diagnostics Market Size and Forecast, 2012-2022. 32
3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 32
3.1.1.2. Market Share Comparison, By Region. 34
3.1.1.3. Y-o-Y growth Comparison, By Region. 34
3.1.2. Germ cell carcinoma tumors Ovarian Cancer Diagnostics Market Size and Forecast, 2012-2022. 35
3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 35
3.1.2.2. Market Share Comparison, By Region. 37
3.1.2.3. Y-o-Y growth Comparison, By Region. 37
3.1.3. Stromal carcinoma tumors Ovarian Cancer Diagnostics Market Size and Forecast, 2012-2022. 38
3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 38
3.1.3.2. Market Share Comparison, By Region. 40
3.1.3.3. Y-o-Y growth Comparison, By Region. 40

Continued………..

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=51

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Ovarian Cancer Diagnostics Market Share, Trends Analysis, Growth Facts and Industry Forecast to 2022 here

News-ID: 1032078 • Views:

More Releases from Fact.MR

Vegan Flavors Market Is Slated To Reach US$ 18,324.3 Million At A CAGR Of 5.2% B …
The global vegan flavor market is estimated to be valued at US$ 11,078.2 million in 2024 and is forecast to reach a value of US$ 18,324.3 million by 2034, with a projected CAGR of 5.2% from 2024 to 2034 owing to the rising popularity of plant-based diets. The Vegan Flavor Industry sales study offers a comprehensive analysis on diverse features including production capacities, Vegan Flavor demand, product developments, sales revenue generation
Pesticide Inert Ingredients Market Is Projected To Reach A Value Of US$ 13,167.2 Million By 2034: Fact.MR Report
Pesticide Inert Ingredients Market Is Projected To Reach A Value Of US$ 13,167.2 …
The global pesticide inert ingredients market is estimated to attain a valuation of US$ 7,621.2 million in 2024. During the forecast period, 2024-2034, the demand for pesticide-inert ingredients is expected to advance at a 5.6% CAGR globally. By 2034, the industry is expected to have grown to a valuation of US$ 13,167.2 million in size. The Pesticide Inert Ingredients Industry sales study offers a comprehensive analysis on diverse features including production
Portable Bluetooth Speaker Market Is Projected To Reach A Value Of US$ 20,521 Million At A CAGR Of 10.6% By 2034
Portable Bluetooth Speaker Market Is Projected To Reach A Value Of US$ 20,521 Mi …
The global portable bluetooth speaker market is estimated to be valued at US$ 7,521.6 million in 2024. The market is anticipated to reach US$ 20,521 million by 2034, with a projected CAGR of 10.6% from 2024 to 2034. The Portable Bluetooth Speaker Industry sales study offers a comprehensive analysis on diverse features including production capacities, Portable Bluetooth Speaker demand, product developments, sales revenue generation and Portable Bluetooth Speaker market outlook
Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2034: Fact.MR Report
03-29-2024 | Health & Medicine
Fact.MR
Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2 …
The global atrial fibrillation devices market (心房細動装置市場) size stands at a valuation of US$ 6.52 billion in 2024, with forecasts predicting a surge to US$ 24.76 billion by the conclusion of 2034. Sales of atrial fibrillation devices worldwide are expected to witness an impressive compound annual growth rate (CAGR) of 14.3% from 2024 to 2034. In recent years, the global healthcare landscape has witnessed a significant surge in the prevalence of

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top